<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Isynbio-Siat on Bioecon</title><link>https://en.bioecon.ru/companies/isynbio-siat/</link><description>Recent content in Isynbio-Siat on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sat, 04 Jul 2026 11:02:22 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/isynbio-siat/index.xml" rel="self" type="application/rss+xml"/><item><title>Venture studios &amp; biotech incubators</title><link>https://en.bioecon.ru/technology/venture-studios-biotech-incubators/</link><pubDate>Sat, 04 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/venture-studios-biotech-incubators/</guid><description>Specialized venture studios, wet-lab accelerators and academic nonprofit networks that convert university biotech IP into funded companies, closing the gap between a PhD discovery and a commercial spin-off.</description></item><item><title>Minimal genomes &amp; synthetic cells</title><link>https://en.bioecon.ru/technology/minimal-genomes-synthetic-cells/</link><pubDate>Fri, 26 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/minimal-genomes-synthetic-cells/</guid><description>The frontier of building life de novo — stripping genomes down to a minimal viable chassis (top-down) and assembling artificial cells from non-living parts (bottom-up) to make predictable, biocontained cell factories.</description></item></channel></rss>